서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 28 of 28

Issue DateTitle / Author(s) / CitationFileAltmetrics
2002-03
Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression

Jong, Hyun-Soon; Lee, Ho Soon; Kim, Tae You; Im, Young-Hyuck; Park, Jae-Won; Kim, Noe Kyeong; Bang, Yung-Jue

Biochemical and Biophysical Research Communications, Vol.292 No.2, pp.383-389

DOI
2004-12
A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma
DOI
2005-11
Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas
DOI
2007-05
The Orientia tsutsugamushi genome reveals massive proliferation of conjugative type IV secretion system and host-cell interaction genes
DOI
2010-10
Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less
view fileDOI
2011-03
Antitumor activity of HM781-36B, an irreversible Pan-HER inhibitor, alone or in combination with cytotoxic chemotherapeutic agents in gastric cancer
DOI
2011-08
Detection of ALK gene rearrangement in non-small cell lung cancer: A comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression
DOI
2012-04
The Prognostic Significance of HER2 Positivity for Advanced Gastric Cancer Patients Undergoing First-line Modified FOLFOX-6 Regimen
2012-04
NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations

Park, Eunju; Park, Jinah; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue

International Journal of Oncology, Vol.40 No.4, pp.1259-1266

DOI
2012-07
MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome

Lee, H. E.; Kim, M. A.; Lee, H. S.; Jung, E-J; Yang, H-K; Lee, B. L.; Bang, Y-J; Kim, W. H.

British Journal of Cancer, Vol.107 No.2, pp.325-333

DOI
2013-03
Concordance of ATM (ataxia telangiectasia mutated) immunohistochemistry between biopsy or metastatic tumor samples and primary tumors in gastric cancer patients
DOI
2014-05
Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas

Seo, A. N.; Yang, J. M.; Kim, H.; Jheon, S.; Kim, K.; Lee, C. T.; Jin, Y.; Yun, S.; Chung, J-H; Paik, J. H.

British Journal of Cancer, Vol.110 No.11, pp.2688-2699

DOI
2014-08
Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer

Keam, Bhumsuk; Kim, Dong-Wan; Park, Jin Hyun; Lee, Jeong-Ok; Kim, Tae Min; Lee, Se-Hoon; Chung, Doo Hyun; Heo, Dae Seog

International Journal of Clinical Oncology, Vol.19 No.4, pp.594-600

DOI
2015-01
In vitro anticancer activity of PI3K alpha selective inhibitor BYL719 in head and neck cancer
2015-12
Mechanisms of Acquired Resistance to AZD9291 A Mutation-Selective, Irreversible EGFR Inhibitor
DOI
2016-04
Metabolic landscape of advanced gastric cancer according to HER2 and its prognostic implications
DOI
2016-06
Comprehensive genetic exploration of skeletal dysplasia using targeted exome sequencing
DOI
2016-12
Proposal of a Provisional Classification of Sebaceous Carcinoma Based on Hormone Receptor Expression and HER2 Status

Na, Hee Young; Choe, Ji-Young; Shin, Seon Ah; Choung, Ho-kyung; Oh, Sohee; Chung, Jin-haeng; Park, Mira; Kim, Ji Eun

American Journal of Surgical Pathology, Vol.40 No.12, pp.1622-1630

DOI
2017-04
MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics
DOI
2017-08
A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer
DOI
2017-09
Human Epidermal Growth Factor Receptor 2 Expression in Unresectable Gastric Cancers: Relationship with CT Characteristics

Lee, Jeong Sub; Kim, Se Hyung; Im, Seock-Ah; Kim, Min A.; Han, Joon Koo

Korean Journal of Radiology, Vol.18 No.5, pp.809-820

DOI
2017-10
Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer
DOI
2018-11
Phase Ib/II study of capmatinib (INC280) plus gefitinib after failure of epidermal growth factor receptor (EGFR) inhibitor therapy in patients with EGFR-mutated, MET factor-dysregulated non-small-cell lung cancer
DOI
2018-12
dCas9-mediated nanoelectrokinetic direct detection of target gene for liquid biopsy
DOI
2020-02
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
DOI
2021-08
Genomic Profiling of Premenopausal HR+ and HER2-Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and Ribociclib
DOI
2023-05
Genetic and immune microenvironment characterization of HER2-positive gastric cancer: Their association with response to trastuzumab-based treatment
DOI
2024-04
Phase II study investigating the efficacy and safety of glesatinib (MGCD265) in patients with advanced NSCLC containing MET activating alterations
DOI
1